Logo wahanariau.com
  2. Boehringer ingelheim

Boehringer ingelheim

Index
Globenewswire

Boehringer Ingelheim Strengthens Antibody-drug Conjugate Portfolio with New NBE Therapeutics R&D Center in Basel

Kamis, 03 April 2025 - 14:30:00 Wib
Globenewswire

Boehringer Ingelheim Reaches More Patients in 2024 and Prepares New Medicine Launches

Rabu, 02 April 2025 - 23:54:20 Wib
Globenewswire

Boehringer Ingelheim Launches New Trivalent Poultry Vaccine, Includes Protection Against H5 Avian Influenza

Senin, 24 Februari 2025 - 17:00:00 Wib
Globenewswire

Boehringer Ingelheim and Partners Start Clinical Development of a First-in-class, Inhaled Gene Therapy for People with Cystic Fibrosis

Kamis, 20 Februari 2025 - 23:26:39 Wib
Globenewswire

Boehringer’s Zongertinib Receives Priority Review from U.S. FDA for the Treatment of HER2 (ERBB2)-mutant Advanced Non-small Cell Lung Cancer

Rabu, 19 Februari 2025 - 23:10:27 Wib
Globenewswire

Boehringer’s Nerandomilast Meets Primary Endpoint in Phase III Study FIBRONEER™-ILD, in Progressive Pulmonary Fibrosis

Senin, 10 Februari 2025 - 20:30:00 Wib
Globenewswire

Boehringer Provides Update on Iclepertin Phase III Program in Schizophrenia

Kamis, 16 Januari 2025 - 22:30:00 Wib
Globenewswire

Boehringer’s Focus on Health Equity Drives Significant Upgrade in Access to Medicine Index Ranking

Selasa, 19 November 2024 - 20:30:00 Wib
Globenewswire

Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative Join Forces to Combat Vision Loss from Diabetes

Selasa, 12 November 2024 - 17:30:00 Wib
Globenewswire

Boehringer Ingelheim and WHO Foundation Join Forces to Promote Equitable Access to Healthcare and Increase Efforts for Suicide Prevention

Selasa, 15 Oktober 2024 - 17:00:00 Wib
Globenewswire

Boehringer Receives U.S. FDA Breakthrough Therapy Designation and Initiates Two Phase III Trials in MASH for Survodutide

Selasa, 08 Oktober 2024 - 14:00:00 Wib
Globenewswire

Boehringer Ingelheim Partners with NCD Alliance to Target Non-Communicable Diseases in Underserved Communities

Jumat, 27 September 2024 - 22:47:56 Wib
Globenewswire

Boehringer Ingelheim Expands Cancer Research at its Vienna Site

Rabu, 25 September 2024 - 22:00:00 Wib
Globenewswire

Boehringer’s Nerandomilast Meets Primary Endpoint in Pivotal Phase-III FIBRONEER™-IPF Study

Senin, 16 September 2024 - 17:30:00 Wib
Globenewswire

Boehringer’s Zongertinib Shows Encouraging Efficacy and Tolerability Profile in Previously Treated HER2 Mutated Lung Cancer Patients

Selasa, 10 September 2024 - 04:39:42 Wib
Globenewswire

Boehringer Ingelheim Announces Plans to Advance Potential New Treatment for Geographic Atrophy, Following Positive Phase I Results

Kamis, 05 September 2024 - 22:00:00 Wib
Globenewswire

Boehringer Ingelheim Acquires Saiba Animal Health, Adding Innovative Technology Platform to its Pet Therapeutics R&D Portfolio

Selasa, 03 September 2024 - 14:10:00 Wib
Globenewswire

Boehringer Ingelheim to Unveil Groundbreaking Oncology Research at WCLC, Demonstrating Strength of Portfolio

Selasa, 27 Agustus 2024 - 14:30:00 Wib
Globenewswire

CHMP Adopts Positive Opinion Recommending Approval of New and Expanded Indications for SPEVIGO®

Senin, 29 Juli 2024 - 13:30:00 Wib
Globenewswire

First half of 2024: Boehringer Ingelheim Progresses Pipeline at Pace and Reaches Major Milestones

Kamis, 18 Juli 2024 - 14:30:00 Wib
Globenewswire

Boehringer Ingelheim Produces its Own Green Energy

Selasa, 09 Juli 2024 - 20:53:12 Wib
Globenewswire

Outdated Perceptions and Practices Fuelling Mental Health Crisis, New Economist Impact Study Reveals

Rabu, 29 Mei 2024 - 22:01:21 Wib
Globenewswire

Boehringer Ingelheim Shares Positive Results from the First Study Worldwide in Diabetic Macular Ischemia

Selasa, 07 Mei 2024 - 10:26:16 Wib
Globenewswire

Less than Half of Veterinary Professionals Feel Their Profession is Appreciated

Jumat, 26 April 2024 - 03:51:07 Wib
Globenewswire

Boehringer Ingelheim Reports Strong Growth in 2023 and Accelerates Late-stage Pipeline

Rabu, 17 April 2024 - 05:27:28 Wib